möLab GmbH

möLab GmbH is a German diagnostics company that positions itself as one of the country's leading and forward-looking manufacturers and trading houses in immunological rapid diagnostics, drug diagnostics, and therapeutic drug monitoring. The company operates under the tagline "möLab – Point of Care," reflecting its focus on delivering diagnostic results directly at the site of patient care, where fast decisions are critical. möLab's product portfolio is organized around three core areas. The first is rapid diagnostics (Schnelldiagnostik): möLab rapid tests deliver results within minutes, enabling medical staff — for example in emergency medicine — to initiate life-saving measures quickly. The second is drug diagnostics (Drogendiagnostik): möLab rapid tests allow the fast, qualitative detection of drugs, drug metabolites, and medications in urine or saliva, and are used in public institutions, clinical laboratories, hospitals, established substitution practices, and companies. The third is aggregation (Aggregation): möLab offers modern aggregation devices and reagents for platelet function diagnostics and therapeutic drug monitoring, supporting the diagnosis of coagulation disorders and the analysis of platelet function. According to the company, möLab has been a competent and reliable partner in these fields since 1983, giving it more than 40 years of experience. Its activities, services, and products are concentrated on rapid diagnostics and related point-of-care applications. The company is headquartered in Germany and serves the German market, describing itself as a nationwide leader among manufacturers and trading companies in its niche. As a privately held company, möLab does not appear to be listed on a public stock exchange. Its identity is closely tied to the point-of-care diagnostics segment, where speed, reliability, and practical usability in clinical and institutional settings are the primary value propositions.

möLab GmbH states that it has been a competent and reliable partner in its fields since 1983, giving the company more than 40 years of experience as of the mid-2020s. Over that period it has built a business focused on point-of-care diagnostics, combining manufacturing and trading activities. The company's development has been organized around three application areas that reflect the evolution of point-of-care testing in clinical and institutional settings. Rapid diagnostics addresses the need for immediate results in settings such as emergency medicine, where treatment decisions must be made on the spot. Drug diagnostics serves public institutions, clinical laboratories, hospitals, substitution practices, and companies that require fast qualitative detection of drugs, drug metabolites, and medications in urine or saliva. Aggregation covers platelet function diagnostics and therapeutic drug monitoring, with modern aggregation devices and reagents supporting the diagnosis of coagulation disorders. By positioning itself as "möLab – Point of Care," the company has aligned its identity with the broader shift of diagnostic testing from centralized laboratories toward the patient's immediate care environment. It describes itself as one of Germany's leading and forward-looking manufacturers and trading companies in immunological rapid diagnostics, drug diagnostics, and therapeutic drug monitoring, and it markets its products nationwide in Germany. The company remains privately held and active.

• 1983

  möLab GmbH begins operations, according to the company's own account, marking the start of more than 40 years of experience in diagnostics.

One of Germany's leading and forward-looking manufacturers and trading companies in immunological rapid diagnostics, drug diagnostics, and therapeutic drug monitoring, emphasizing point-of-care speed and reliability.

• Rapid diagnostic tests (Schnelldiagnostik)

  Point-of-care rapid tests that deliver results within minutes, supporting rapid decision-making in settings such as emergency medicine.

• Drug diagnostics tests (Drogendiagnostik)

  Rapid tests for the qualitative detection of drugs, drug metabolites, and medications in urine or saliva, used in public institutions, clinical laboratories, hospitals, substitution practices, and companies.

• Aggregation devices and reagents

  Modern aggregation instruments and reagents for platelet function diagnostics and therapeutic drug monitoring, supporting diagnosis of coagulation disorders.

1. 1möLab – Point of Caremoelab.de
2. 2möLab GmbH – Wikidatawikidata.org